Violet Light for the Suppression of Myopia
Key facts
- Who runs it
- Children's Hospital Medical Center, Cincinnati
- Where
- Cincinnati, United StatesSee the site
- Trial code
- Status
- Terminated
- People taking part
- 65 people enrolled
- Started
- 7 Jun 2023
- Ended
- 6 Jul 2026
- Type of study
- Interventional, 3 groupsOne group gets a placebo (a dummy treatment), for comparison.
- Treatments tested
- Violet Light Lamp
- White Light Lamp
- Record updated
- 10 July 2026
- Why it stopped
- Recruitment issues.
Who can take part
- Age
- 5 years to 12 years
- Sex
- Women and men
- Healthy volunteers
- Can take part
The registry criteria, word for word
Show all 12 criteriaShow less
Who can take part
- Children must be between 5 to <13 years old
- Diagnosis of Myopia (ICD-10-CM Diagnosis; Code H52.13) with refractive error:
- Myopia -1.00D to -6.00D spherical equivalent (SE) in both eyes
- Astigmatism <=1.50D in both eyes
- Anisometropia <=1.00D SE • Relocation outside of the CCHMC area within the next 12 months is not anticipated
Who cannot take part
- Current or previous myopia treatment with atropine, pirenzepine, or other antimuscarinic agents
- Current or previous use of bifocals, progressive addition lenses, or multi-focal contact lenses
- Current or previous use of orthoK, rigid gas permeable, or other contact lenses being used to reduce myopia progression
- Current or prior history of manifest strabismus, amblyopia, or nystagmus
- Prior eyelid, strabismus, intraocular, or refractive surgery
- Down syndrome or cerebral palsy
- Abnormality of cornea, lens, central retina, iris, or ciliary body
Where in United States
- Cincinnati Children's Hospital Medical CenterCincinnati, United States
About the trial
What the trial wants to find out
The study explores the suppression of myopia via violet light.
The 3 groups in the trial
- Violet + / Lens +Treatment being tested
Subjects use a violet light emitting lamp (device intervention - minimally invasive as it's simply a source of light) with CR-39 lenses for their refractive correction. The lamp introduces violet light (Violet +) and the CR-39 lenses allow for the transmission of violet light through the lenses (Lens +).
Treatment: Violet Light Lamp
- Violet + / Lens -Treatment being tested
Subjects use a violet light emitting lamp (device intervention - minimally invasive as it's simply a source of light) with polycarbonate lenses for their refractive correction. The lamp introduces violet light (Violet +) while the polycarbonate lenses block the transmission of violet light through the lenses (Lens -).
Treatment: Violet Light Lamp
- Violet - / Lens +Placebo, for comparison
Subjects use a lamp with NO violet light (Violet -) with CR-39 lenses for their refractive correction. CR-39 lenses allow for the transmission of violet light through the lenses (Lens +).
Treatment: White Light Lamp
Data and sources
- Registry record
- Listed on ClinicalTrials.gov.How to verify a trial in the registry
- Official title
- Violet Light for Treatment of Myopia
- Record updated
- 10 July 2026